As can be seen from Fig. 8H and Additional file 3: Figure S3H, more mutated genes can be detected in tissues of patients with gastric cancer compared with arterial CTCs and venous CTCs, the mutated genes targeted with clinically available drugs (EGFR exon19) were detected in tissues and arterial CTCs at the same time. The gene discussed is EGFR; the disease is gastric cancer.